Literature summary for 2.7.11.15 extracted from

Cannavo, A.; Liccardo, D.; Lymperopoulos, A.; Gambino, G.; DAmico, M.L.; Rengo, F.; Koch, W.J.; Leosco, D.; Ferrara, N.; Rengo, G.
beta Adrenergic receptor kinase c-terminal peptide gene-therapy improves beta2-adrenergic receptor-dependent neoangiogenesis after hindlimb ischemia (2016), J. Pharmacol. Exp. Ther., 356, 503-513.

Search for more literature for 2.7.11.15

Inhibitors

Inhibitors	Comment	Organism	Structure
beta adrenergic receptor kinase C-terminal peptide	-	Rattus norvegicus

Natural Substrates/ Products (Substrates)

Natural Substrates	Organism	Comment (Nat. Sub.)	Natural Products	Comment (Nat. Pro.)	Rev.	Reac.
ATP + [beta-adrenergic receptor]	Rattus norvegicus	-	ADP + phospho-[beta-adrenergic receptor]	-	?

Organism

Organism	UniProt	Comment	Textmining
Rattus norvegicus	-	-	-

Source Tissue

Source Tissue	Comment	Organism	Textmining
skeletal muscle	-	Rattus norvegicus	-

Substrates and Products (Substrate)

Substrates	Comment Substrates	Organism	Products	Comment (Products)	Rev.	Reac.
ATP + [beta-adrenergic receptor]	-	Rattus norvegicus	ADP + phospho-[beta-adrenergic receptor]	-	?

Synonyms

Synonyms	Comment	Organism
G protein-coupled receptor kinase 2	-	Rattus norvegicus
GRK2	-	Rattus norvegicus

Expression

Organism	Comment	Expression
Rattus norvegicus	15 days of ischemia result in 2-fold increase in enzyme levels in the ischemic muscle	down

Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.

Release 2023.1 (January 2023)